Endocan in Cancers: A Lesson from a Circulating Dermatan Sulfate Proteoglycan
Open Access
- 1 January 2013
- journal article
- review article
- Published by Hindawi Limited in International Journal of Cell Biology
- Vol. 2013, 1-11
- https://doi.org/10.1155/2013/705027
Abstract
As most proteoglycans exert their biological activities in the pericellular region, circulating Endocan has appeared since its discovery as an atypical dermatan sulfate proteoglycan, with distinctive structural and functional properties. Endocan is naturally expressed by endothelial cells, highly regulated in presence of proinflammatory and proangiogenic molecules, binds to matrix proteins, growth factors, integrin, and cells, and may be then considered as an accurate marker of endothelial activation. Consequently, Endocan expression has been associated with a growing number of pathological conditions where endothelium gets challenged and notably in highly vascularized cancers. In this context, Endocan has indeed been rapidly emerging as a promising tissue- and blood-based marker of the vascular growth and neoangiogenesis during cancer progression. Furthermore, very recent studies have reported an expression of Endocan by the tumor cells themselves. This highlights Endocan as a multifaceted molecule with a great interest for researchers and clinicians to better understand tumor development, from the bench to the clinics. With promising perspectives of clinical applications, Endocan thus appears as an exciting model for on going and future developments of proteoglycan-based approaches in cancer diagnostics and/or therapy.Keywords
Funding Information
- Européen de Développement Économique et Régional
This publication has 91 references indexed in Scilit:
- Prospective Identification of Glioblastoma Cells Generating Dormant TumorsPLOS ONE, 2012
- A new alternative mechanism in glioblastoma vascularization: tubular vasculogenic mimicryBrain, 2010
- Identification of Genes and Pathways Involved in Retinal Neovascularization by Microarray Analysis of Two Animal Models of Retinal AngiogenesisInvestigative Ophthalmology & Visual Science, 2010
- Proteoglycan signaling co-receptors: Roles in cell adhesion, migration and invasionCellular Signalling, 2009
- The signaling mechanisms of syndecan heparan sulfate proteoglycansCurrent Opinion in Cell Biology, 2009
- Transcriptional Switch of Dormant Tumors to Fast-Growing Angiogenic PhenotypeCancer Research, 2009
- Diverse Cell Signaling Events Modulated by PerlecanBiochemistry, 2008
- Transcriptional profiling of VEGF-A and VEGF-C target genes in lymphatic endothelium reveals endothelial-specific molecule-1 as a novel mediator of lymphangiogenesisBlood, 2008
- Loss of Endocan tumorigenic properties after alternative splicing of exon 2BMC Cancer, 2008
- Tumor Angiogenesis: Therapeutic ImplicationsThe New England Journal of Medicine, 1971